Efficacy and Safety of Voxelotor in Sickle Cell Disease: A Systematic Review

被引：0
|
作者：
Ali, Muhammad Ashar
Khan, Anam
Khan, Sana Irfan
Aamir, Sobia
Rahman, Saad Ur
Waqar, Anum
Chaudry, Hafsa Tahir
Anwar, Muhammad Yasir
Aiman, Wajeeha
Anwer, Faiz
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-135960
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Voxelotor in sickle cell disease
    Bain, Barbara J.
    Myburgh, Jane
    Hann, Amanda
    Layton, D. Mark
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 830 - 832
  • [2] Safety and Efficacy of Hydroxyurea in Pediatric Sickle Cell Disease: A Comprehensive Systematic Review
    Hadia, Rajesh
    Bhil, Dipika
    Maheshwari, Rajesh
    [J]. ASIAN JOURNAL OF PHARMACEUTICS, 2023, 17 (04) : 701 - 721
  • [3] Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years
    Estepp, Jeremie H.
    Kalpatthi, Ram
    Woods, Gerald
    Trompeter, Sara
    Liem, Robert I.
    Sims, Kacie
    Inati, Adlette
    Inusa, Baba P. D.
    Campbell, Andrew
    Piccone, Connie
    Abboud, Miguel R.
    Smith-Whitley, Kim
    Dixon, Sandra
    Tonda, Margaret
    Washington, Carla
    Griffin, Noelle M.
    Brown, Clark
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [4] INTERIM SAFETY AND EFFICACY OF VOXELOTOR IN CHILDREN AGED 2 to <4 YEARS WITH SICKLE CELL DISEASE
    Fuh, Beng
    Inati, Adlette
    Inusa, Baba
    Abboud, Miguel
    Norris, Cynthia
    Kalpatthi, Ramasubramanian
    Telfer, Paul
    Trompeter, Sara
    Dixon, Sandy
    Enriquez, Aimee
    Akhlaghi, Fatemeh
    Smith-Whitley, Kim
    Brown, Clark
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S163 - S164
  • [5] Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review
    Dick, Maurice H.
    Abdelgadir, Arowa
    Kulkarni, Vaishnavi Vijaya
    Akram, Hamna
    Chatterjee, Abanti
    Pokhrel, Sushil
    Khan, Safeera
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [6] Systematic Review of Voxelotor: A First-in-Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease
    Han, Jin
    Saraf, Santosh L.
    Gordeuk, Victor R.
    [J]. PHARMACOTHERAPY, 2020, 40 (06): : 525 - 534
  • [7] Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
    Alshurafa, Awni
    Yassin, Mohamed A. A.
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [8] Voxelotor for the treatment of sickle cell disease
    Vissa, Madhav
    Vichinsky, Elliott
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (03) : 253 - 261
  • [9] Efficacy and Safety of Voxelotor in Adolescents and Adults with Sickle Cell Disease: HOPE Trial 72-Week Analysis
    Howard, Jo
    Ataga, Kenneth I.
    Brown, R. Clark
    Achebe, Maureen
    Nduba, Videlis
    El-Beshlawy, Amal
    Hassab, Hoda
    Agodoa, Irene
    Tonda, Margaret
    Gray, Sarah
    Lehrer-Graiwer, Joshua
    Vichinsky, Elliott
    [J]. BLOOD, 2020, 136
  • [10] Voxelotor: A Novel Treatment for Sickle Cell Disease
    Herity, Leah B.
    Vaughan, DaleMarie M.
    Rodriguez, Lindsey Ftitenour
    Lowe, Denise Kozella
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (02) : 240 - 245
12345